-
Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21 Clinical Trial Optional)
(PA-18-271)
National Institute of Mental Health
National Institute of Nursing Research
Application Receipt Date(s): Standard AIDS dates apply , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21 Clinical Trial Optional)
(PA-18-272)
National Institute of Mental Health
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Targeted basic behavioral and social science and intervention development for HIV prevention and care (R01 Clinical Trial Optional)
(PA-18-273)
National Institute of Mental Health
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R01 Clinical Trial Optional)
(PA-18-274)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R21 Clinical Trial Optional)
(PA-18-275)
National Institute of Mental Health
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional)
(PA-18-276)
National Institute of Mental Health
Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R21 Clinical Trial Optional)
(PA-18-277)
National Institute of Mental Health
National Institute of Nursing Research
Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on .
-
Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R01 Clinical Trial Optional)
(PA-18-278)
National Institute of Mental Health
National Institute of Nursing Research
Application Receipt Date(s): Standard AIDS dates apply or Month(s) Day(s), Year(s), by 5:00 PM local time of applicant organization. All types of AIDS- applications allowed for this funding opportunity announcement are due on these dates.
-
Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R01 Clinical Trial Optional)
(PA-18-279)
National Institute of Mental Health
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21 Clinical Trial Optional)
(PA-18-280)
National Institute of Mental Health
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R01 Clinical Trial Optional)
(PA-18-281)
National Institute of Mental Health
National Institute of Nursing Research
Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on these dates.
-
Epidemiology and Prevention in Alcohol Research (R01 - Clinical Trial Optional)
(PA-18-390)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Epidemiology and Prevention in Alcohol Research (R21 - Clinical Trial Optional)
(PA-18-391)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIH Pathway to Independence Award (Parent K99/R00 - Clinical Trial Required)
(PA-18-397)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard due date for this FOA is February 12, 2018.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)
(PA-18-398)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Library of Medicine
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard due date for this FOA is February 12, 2018.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Research on Autism Spectrum (R03-Clinical Trial Optional)
(PA-18-399)
National Institute of Mental Health
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Research on Autism Spectrum (R21- Clinical Trial Optional)
(PA-18-400)
National Institute of Mental Health
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Research on Autism Spectrum (R01- Clinical Trial Optional)
(PA-18-401)
National Institute of Mental Health
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Epidemiology and Prevention in Alcohol Research (R03 - Clinical Trial - Optional)
(PA-18-413)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIBIB Research Project Grant (R01 Clinical Trial Required)
(PA-18-418)
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional)
(PAR-18-022)
National Cancer Institute
National Institute on Drug Abuse
Application Receipt Date(s): April 4, 2018; November 1, 2018; April 4, 2019, November 1, 2019, by 5:00 PM local time of applicant organization.
-
Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional)
(PAR-18-023)
National Cancer Institute
National Institute on Drug Abuse
Application Receipt Date(s): April 4, 2018; November 1, 2018; April 4, 2019, November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21 Clinical Trial Optional)
(PAR-18-024)
National Cancer Institute
Application Receipt Date(s): April 11, 2018; October 10, 2018; April 11, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
NIDDK Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)
(PAR-18-108)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
(PAR-18-111)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): June 1, 2018; November 1, 2018, by 5:00 PM local time of applicant organization.
-
NCCIH Natural Product Phase II Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
(PAR-18-125)
National Center for Complementary and Integrative Health
Application Receipt Date(s): New Applications: June 7, 2018; February 7, 2019; and October 8, 2019
Resubmission, Revision, and Renewal Applications: October 20, 2017; June 21, 2018; February 21, 2019; and October 21, 2019
, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Strategies to Increase Delivery of Guideline-Based Care to Populations with Health Disparities (R01 Clinical Trial Optional)
(PAR-18-133)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): June 21, 2018 by 5:00 PM local time of applicant organization.
-
Building Evidence: Effective Palliative/End of Life Care Interventions (R01 Clinical Trial Optional)
(PAR-18-173)
National Institute of Nursing Research
Application Receipt Date(s): June 11, 2018; October 8, 2018; June 10, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)
(PAR-18-183)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)
(PAR-18-184)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42 Clinical Trial Optional)
(PAR-18-185)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
*** Note new SBIR/STTR Standard Due Dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44 Clinical Trial Optional)
(PAR-18-186)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
*** Note new SBIR/STTR Standard Due Dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
(PAR-18-189)
National Institute on Aging
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
(PAR-18-190)
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Wearable Alcohol Biosensors (R43/R44 Clinical Trial Optional)
(PAR-18-204)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization.
*** Note new SBIR/STTR Standard Due Dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
(PAR-18-214)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
(PAR-18-215)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NICHD Research Education Programs (R25 Clinical Trial Optional)
(PAR-18-217)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): May 25, 2018; May 25, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Evaluating the NIDA Standardized Research E-Cigarette in Risk Reduction and Related Studies (U01 Clinical Trial Optional)
(PAR-18-220)
National Institute on Drug Abuse
Application Receipt Date(s): April 24, 2018; April 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3 Clinical Trial Optional)
(PAR-18-221)
National Institute on Drug Abuse
Application Receipt Date(s): March 28, 2018 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)
(PAR-18-222)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
Application Receipt Date(s): July 17, 2018; November 13, 2018; July 17, 2019; November 13, 2019; July 17, 2020; November 13, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)
(PAR-18-223)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): July 17, 2018; November 13, 2018; July 17, 2019; November 13, 2019; July 17, 2020; November 13, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
(PAR-18-224)
National Institute on Drug Abuse
Application Receipt Date(s): September 25, 2018, by 5:00 PM local time of applicant organization.
-
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
(PAR-18-225)
National Institute on Drug Abuse
Application Receipt Date(s): September 26, 2018, September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
(PAR-18-226)
National Institute on Drug Abuse
Application Receipt Date(s): October 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21 Clinical Trial Optional)
(PAR-18-242)
John E. Fogarty International Center
National Cancer Institute
National Institute on Deafness and Other Communication Disorders
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Biomedical Imaging and Bioengineering
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): August 31, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)
(PAR-18-246)
National Cancer Institute
Application Receipt Date(s): April 11, 2018; October 10, 2018, April 11, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)
(PAR-18-247)
National Cancer Institute
Application Receipt Date(s): April 11, 2018; October 10, 2018, April 11, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional)
(PAR-18-248)
National Cancer Institute
Application Receipt Date(s): May 9, 2018; September 12, 2018; January 9, 2019; May 9, 2019; September 12, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)
(PAR-18-249)
National Cancer Institute
Application Receipt Date(s): May 9, 2018; September 12, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21 Clinical Trial Optional)
(PAR-18-250)
National Cancer Institute
Application Receipt Date(s): June 13, 2018; October 11, 2018, June 13, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional)
(PAR-18-251)
National Cancer Institute
Application Receipt Date(s): June 13, 2018; October 11, 2018, June 13, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Image-guided Drug Delivery (R01 Clinical Trial Optional)
(PAR-18-252)
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): June 21, 2018; November 22, 2018, by 5:00 PM local time of applicant organization.
-
Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow Projects (R01 Clinical Trial Optional)
(PAR-18-254)
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt Date(s): May 8, 2018, by 5:00 PM local time of applicant organization.
-
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)
(PAR-18-263)
National Institute of General Medical Sciences
Application Receipt Date(s): May 28, 2018; and May 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE)(P20 Clinical Trial Optional)
(PAR-18-264)
National Institute of General Medical Sciences
Application Receipt Date(s): September 28, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Institutional Development Award (IDeA) Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 Clinical Trial Optional)
(PAR-18-265)
National Institute of General Medical Sciences
Application Receipt Date(s): October 2, 2018; October 2, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Centers of Biomedical Research Excellence (COBRE) (P20 Clinical Trial Optional)
(PAR-18-266)
National Institute of General Medical Sciences
Application Receipt Date(s): January 24, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
Products to Support Applied Research Towards Zero Suicide Healthcare Systems (R43/R44 Clinical Trial Optional)
(PAR-18-269)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
Health Services Research on Minority Health and Health Disparities (R01 Clinical Trial Optional)
(PAR-18-286)
National Institute on Minority Health and Health Disparities
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Application Receipt Date(s): April 11, 2018; April 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Health Services Research on Minority Health and Health Disparities (R21 Clinical Trial Optional)
(PAR-18-287)
National Institute on Minority Health and Health Disparities
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Application Receipt Date(s): April 11, 2018; April 11, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Surgical Disparities Research (R01 Clinical Trial Optional)
(PAR-18-288)
National Institute on Minority Health and Health Disparities
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Nursing Research
Office of Research on Women's Health
Application Receipt Date(s): June 7, 2018 and June 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Exploratory/Developmental Surgical Disparities Research (R21 Clinical Trial Optional)
(PAR-18-289)
National Institute on Minority Health and Health Disparities
National Cancer Institute
Office of Research on Women's Health
Application Receipt Date(s): June 7, 2018 and June 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
(PAR-18-292)
National Cancer Institute
Application Receipt Date(s): June 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIDDK Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
(PAR-18-414)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIDDK Multi-Center Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
(PAR-18-415)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NHLBI Career Transition Award for Intramural Fellows (K22) (No Independent Clinical Trials)
(PAR-18-416)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 - Clinical Trials Required)
(PAR-18-417)
National Center for Complementary and Integrative Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIDDK Mentored Research Scientist Development Award (K01-Clinical Trial Required)
(PAR-18-418)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDDK Mentored Research Scientist Development Award (K01-No Independent Clinical Trials)
(PAR-18-419)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NINDS Exploratory Clinical Trials (U01 - Clinical Trials Required)
(PAR-18-420)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NINDS Program Project Grant (P01) - Clinical Trial Optional
(PAR-18-421)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NINDS Efficacy Clinical Trials (U01) - Clinical Trial Required
(PAR-18-422)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDDK Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
(PAR-18-423)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): April 10, 2018; November 1, 2018; June 3, 2019; February 3, 2020; November 2, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NHLBI Career Transition Award for Intramural Fellows (K22) (Clinical Trials Required)
(PAR-18-424)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDA Program Project Grant Applications (P01, Clinical Trial Optional)
(PAR-18-425)
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trials Not Allowed)
(PAR-18-462)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NHLBI Clinical Trial Pilot Studies (R34 - Clinical Trial Optional)
(PAR-18-463)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R43/R44 Clinical Trial Optional)
(PAS-18-120)
National Center for Complementary and Integrative Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
*** Note new SBIR/STTR Standard Due Dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R41/R42 Clinical Trial Optional)
(PAS-18-121)
National Center for Complementary and Integrative Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
*** Note new SBIR/STTR Standard Due Dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
(PAS-18-187)
National Institute on Aging
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization.
-
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
(PAS-18-188)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
Collaboratory on Research Definitions for Cognitive Reserve and Resilience to Alzheimer's Disease (R24 - Clinical Trial Not Allowed)
(RFA-AG-18-024)
National Institute on Aging
Application Receipt Date(s): February 22, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
(RFA-AI-17-042)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): March 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Innovative Research in HIV in Kidney, Urology, and Hematology (R01 Clinical Trial Optional)
(RFA-DK-17-037)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): March 13, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Research on Pre-Exposure Prophylaxis (PrEP) to Prevent HIV in Health Disparity Populations (R01-Clinical Trial Not Allowed)
(RFA-MD-18-003)
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): February 28, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Youth Violence Prevention Interventions that Incorporate Racism/Discrimination Prevention (R01-Clinical Trial Required)
(RFA-MD-18-005)
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): May 25, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this dates.
-
NIH-CASIS Coordinated Microphysiological Systems Program for Translational Research in Space (UG3/UH3) (Clinical Trials Not Allowed)
(RFA-TR-18-001)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): February 8, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.